Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 3481 AL 3495

How the cognitive reserve interacts with β-amyloid deposition in mitigating FDG metabolism: An observational study

Carapelle E, Serra L, Modoni S, Falcone M, Caltagirone C, Bozzali M, Specchio LM, Avolio C.

Medicine (Baltimore). 2017 Apr;96(16):e5876. doi: 10.1097/MD.0000000000005876.

Applying fluid biomarkers to Alzheimer's disease

Zetterberg H.

Am J Physiol Cell Physiol. 2017 Jul 1;313(1):C3-C10. doi: 10.1152/ajpcell.00007.2017. Epub 2017 Apr 19.

Biomarkers for Early Diagnosis of Alzheimer's Disease in the Oldest Old: Yes or No?

Paolacci L, Giannandrea D, Mecocci P, Parnetti L.

J Alzheimers Dis. 2017;58(2):323-335. doi: 10.3233/JAD-161127.

Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database

Ben Bouallègue F, Mariano-Goulart D, Payoux P; Alzheimer’s Disease Neuroimaging Initiative (ADNI).

Alzheimers Res Ther. 2017 Apr 26;9(1):32. doi: 10.1186/s13195-017-0260-z.

Bryostatin Effects on Cognitive Function and PKCɛ in Alzheimer's Disease Phase IIa and Expanded Access Trials

Nelson TJ, Sun MK, Lim C, Sen A, Khan T, Chirila FV, Alkon DL.

J Alzheimers Dis. 2017;58(2):521-535. doi: 10.3233/JAD-170161.

Detectable Neuropsychological Differences in Early Preclinical Alzheimer's Disease: A Meta-Analysis

Duke Han S, Nguyen CP, Stricker NH, Nation DA.

Neuropsychol Rev. 2017 Dec;27(4):305-325. doi: 10.1007/s11065-017-9345-5. Epub 2017 May 11.

Evolving Relevance of Neuroproteomics in Alzheimer's Disease

Lista S, Zetterberg H, O'Bryant SE, Blennow K, Hampel H.

Methods Mol Biol. 2017;1598:101-115. doi: 10.1007/978-1-4939-6952-4_5.

Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease

Sala I, Illán-Gala I, Alcolea D, Sánchez-Saudinós MB, Salgado SA, Morenas-Rodríguez E, Subirana A, Videla L, Clarimón J, Carmona-Iragui M, Ribosa-Nogué R, Blesa R, Fortea J, Lleó A.

J Alzheimers Dis. 2017;58(3):909-918. doi: 10.3233/JAD-170073.

Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus report

Wallin A, Kapaki E, Boban M, Engelborghs S, Hermann DM, Huisa B, Jonsson M, Kramberger MG, Lossi L, Malojcic B, Mehrabian S, Merighi A, Mukaetova-Ladinska EB, Paraskevas GP, Popescu BO, Ravid R, Traykov L, Tsivgoulis G, Weinstein G, Korczyn A, Bjerke M, Rosenberg G.

BMC Neurol. 2017 May 23;17(1):102. doi: 10.1186/s12883-017-0877-3.

Altered peripheral profile of blood cells in Alzheimer disease: A hospital-based case-control study

Chen SH, Bu XL, Jin WS, Shen LL, Wang J, Zhuang ZQ, Zhang T, Zeng F, Yao XQ, Zhou HD, Wang YJ.

Medicine (Baltimore). 2017 May;96(21):e6843. doi: 10.1097/MD.0000000000006843.

PET Imaging for Early Detection of Alzheimer's Disease: From Pathologic to Physiologic Biomarkers

Bao W, Jia H, Finnema S, Cai Z, Carson RE, Huang YH.

PET Clin. 2017 Jul;12(3):329-350. doi: 10.1016/j.cpet.2017.03.001. Epub 2017 May 2.

Plasma REST: a novel candidate biomarker of Alzheimer's disease is modified by psychological intervention in an at-risk population

Ashton NJ, Hye A, Leckey CA, Jones AR, Gardner A, Elliott C, Wetherell JL, Lenze EJ, Killick R, Marchant NL.

Transl Psychiatry. 2017 Jun 6;7(6):e1148. doi: 10.1038/tp.2017.113.

Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons

Donohue MC, Sperling RA, Petersen R, Sun CK, Weiner MW, Aisen PS; Alzheimer’s Disease Neuroimaging Initiative.

JAMA. 2017 Jun 13;317(22):2305-2316. doi: 10.1001/jama.2017.6669.

Concordance between brain (18)F-FDG PET and cerebrospinal fluid biomarkers in diagnosing Alzheimer's disease

Rubí S, Noguera A, Tarongí S, Oporto M, García A, Vico H, Espino A, Picado MJ, Mas A, Peña C, Amer G.

Rev Esp Med Nucl Imagen Mol (Engl Ed). 2018 Jan-Feb;37(1):3-8. doi: 10.1016/j.remn.2017.05.003. Epub 2017 Jun 20.

Self-reported sleep and Alzheimer disease CSF biomarkers: A wake-up call

Spira AP, Ju YS.

Neurology. 2017 Aug 1;89(5):419-420. doi: 10.1212/WNL.0000000000004189. Epub 2017 Jul 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias